Back to Driehaus Capital Management LLC Driehaus Capital Management LLC

CRNXCRNX

26 quarters

Position history for Driehaus Capital Management LLCDriehaus Capital Management LLC's holdings in CRINETICS PHARMACEUTICALS INC

As of its Q2 2026 13F, Driehaus Capital Management held 6,463,551 shares of CRNX (Crinetics Pharmaceuticals), worth $241.9M. Driehaus Capital Management's 13F filings listed CRNX from Q2 2020 to Q2 2026, 25 quarterly filings. CRNX was 1.4% of Driehaus Capital Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$15.5M

Total Shares Change

-886,762

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2026-Q2
Increased
6.5M
+1.1%
$241.9M1.4%$37.42
49
2026-Q1
Increased
6.4M
+0.1%
$232.3M1.7%$36.32
48
2025-Q4
Decreased
6.4M
-1.4%
$297.3M2.0%$46.55
0
2025-Q3
Increased
6.5M
+1.3%
$270M1.9%$41.65
49
2025-Q2
Increased
6.4M
+2.6%
$184.1M1.5%$28.76
49
2025-Q1
Increased
6.2M
+1.6%
$209.3M2.0%$33.54
53
2024-Q4
Increased
6.1M
+4.3%
$314M2.6%$51.13
55
2024-Q3
Decreased
5.9M
-3.7%
$300.7M2.6%$51.10
0
2024-Q2
Increased
6.1M
+16.9%
$273.8M2.6%$44.79
61
2024-Q1
Increased
5.2M
+3.7%
$244.6M2.4%$46.81
55
2023-Q4
Decreased
5M
-1.8%
$179.3M2.2%$35.58
0
2023-Q3
Decreased
5.1M
-3.1%
$152.6M2.0%$29.74
0
2023-Q2
Increased
5.3M
+0.2%
$95.5M1.2%$18.02
47
2023-Q1
Decreased
5.3M
-6.0%
$84.9M1.2%$16.06
0
2022-Q4
Decreased
5.6M
-0.1%
$102.9M1.5%$18.30
0
2022-Q3
Increased
5.6M
+2.9%
$110.6M1.7%$19.64
49
2022-Q2
Increased
5.5M
+10.7%
$102.1M1.7%$18.65
52
2022-Q1
Increased
4.9M
+3.1%
$108.5M1.3%$21.95
49
2021-Q4
Increased
4.8M
+59.9%
$136.2M1.4%$28.41
68
2021-Q3
Increased
3M
+10.7%
$63.1M0.7%$21.05
46
2021-Q2
Increased
2.7M
+35.1%
$51M0.7%$18.85
54
2021-Q1
Increased
2M
+37.8%
$30.6M0.5%$15.28
45
2020-Q4
Increased
1.5M
+66.2%
$20.5M0.3%$14.11
50
2020-Q3
Decreased
874,842
-1.3%
$13.7M0.3%$15.67
0
2020-Q2
New
886,762
—
$15.5M0.4%$17.52
47

Optional analytics helps us improve. How it’s used